Immunophenotypic Analysis of Mast Cells in Mastocytosis: When and How to Do It. Proposals of the Spanish Network on Mastocytosis (REMA)

Cytometry Part B - Clinical Cytometry

Volumn 58, Issue 1, 2004, Pages 1-8

  Escribano, Luis ^a   Diaz Agustin, Beatriz ^a   López, Antonio ^b   Núñez López, Rosa ^a   García Montero, Andrés ^b   Almeida, Julia ^b   Prados, Aranzazu ^a   Angulo, Miguel ^b   Herrero, Sonia ^c   Orfao, Alberto ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD59 ANTIGEN; CD63 ANTIGEN; CD69 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; GLYCOPROTEIN P 15095; INTERLEUKIN 2 RECEPTOR; STEM CELL FACTOR RECEPTOR;

ARTICLE; AUTOFLUORESCENCE; CLINICAL PROTOCOL; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LIGHT SCATTERING; MAST CELL; MASTOCYTOSIS; MEDICAL SOCIETY; PHENOTYPIC VARIATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT INDICATION;

EID: 12144286558     PISSN: 15524949     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.b.10072     Document Type: Article

References (23)

1. Schwartz LB, Sakai K, Bradford TR, Ren S, Zweiman B, Worobec AS, Metcalfe DD. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995;96:2702-2710.
2. Horny HP, Sillaber C, Menke D, Kaiserling E, Wehrmann M, Stehberger B, Chott A, Lechner K, Lennert K, Valent P. Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol 1998;22:1132-1140.
3. Escribano L, Orfao A, Díaz Agustín B, Villarrubia J, Cerveró C, López A, García Marcos A, Bellas C, Fernández Cañadas S, Cuevas M, Sanchez A, Velasco JL, Navarro JL, San Miguel JF. Indolent systemic mast cell disease in adults. immunophenotypic characterization and its diagnostic implications. Blood 1997;91:2731-2736.
4. Longley BJ, Tyrrell L, Lu SZ, Ma YS, Langley K, Ding TG, Duffy T, Jacobs P, Tang LH, Modlin I. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 1996;12:312-314.
5. Nagata H, Okada T, Worobec AS, Semere T, Metcalfe DD. C-kit mutation in a population of patients with mastocytosis. Int Arch Allergy Immunol 1997;113:184-186.
6. Pignon JM, Giraudier S, Duquesnoy P, Jouault H, Imbert M, Vainchenker W, Vernant JP, Tulliez M. A new c-kit mutation in a case of aggressive mast cell disease. Br J Haematol 1997;96:374-376.
7. Yavuz AS, Lipsky PE, Yavuz S, Metcalfe DD, Akin C. Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene. Blood 2002;100:661-665.
8. Nuñez R, Escribano L, Schernthaner G, Prados A, Rodriguez-Gonzalez R, Diaz-Agustin B, Lopez A, Hauswirth A, Valent P, Almeida J, Bravo P, Orfao A. Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis. Br J Haematol 2002;120:257-265.
9. Escribano L, Orfao A, Díaz Agustín B, Cerveró C, Herrero S, Villarrubia J, Bravo P, Torrelo A, Montero T, Valdemoro M, Velasco JL, Navarro JL, San Miguel JF. Human bone marrow mast cells from indolent systemic mast cell disease constitutively express increased amounts of the CD63 protein on their surface. Cytometry 1998;34:223-228.
10. Diaz-Agustin B, Escribano L, Bravo P, Herrero S, Nunez R, Navalon R, Navarro L, Torrelo A, Cantalapiedra A, Del Castillo L, Villarrubia J, Navarro JL, San Miguel JF, Orfao A. The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease. Br J Haematol 1999;106:400-405.
11. Orfao A, Escribano L, Villarrubia. J, Velasco JL, Cerveró C, Ciudad J, Navarro JL, San Miguel JF. Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples. Identification and enumeration. Am J Pathol 1996;149:1493-1499.
12. Escribano L, Orfao A, Villarrubia J, Díaz Agustín B, Cerveró C, Ríos A, Velasco JL, Ciudad J, Navarro JL, San Miguel JF. Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples. Anal Cell Pathol 1998;16:151-159.
13. Escribano L, Ocqueteau M, Almeida J, Orfao A, San Miguel JF. Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. Leuk Lymph 1998;30:459-466.
14. Escribano L, Navalón R, Núñez R, Díaz Agustín B, Bravo P. Flow cytometry immunophenotypic analysis of human mast cells. In: Robinson JP, Darzynkiewicz Z, Dean P, Orfao A, Rabinovitch P, Wheeless L, editors. Current protocols in cytometry. New York: John Wiley & Sons; 2000. p 6.6.1-6.6.18.
15. Gratama JW, Keeney M, Sutherland DR. Enumeration of CD34+ hematopoietic stem cells and progenitors cells. In: Robinson JP, Darzynkiewicz Z, Dean P, Orfao A, Rabinovitch P, Wheeless L, editors. Current protocols in cytometry. New York: John Wiley & Sons; 2000. p 6.4.1-6.4.22.
16. Gratama JW, D'hautcourt JL, Mandy F, Rothe G, Barnett D, Janossy G, Papa S, Schmitz G, Lenkei R, European Working Group Clinical Cell Analysis. Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives. Cytometry 1998;33:166-178.
17. Lenkei R, Gratama JW, Rothe G, Schmitz G, D'hautcourt JL, Årekrans A, Mandy F, Marti G. Performance of calibration standards for antigen quantitation with flow cytometry. Cytometry 1998;33:188-196.
18. US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry; Bethesda, Maryland; 16-17 November 1995. Cytometry 1997;30:213-274.
19. Orfao A, Schmitz G, Brando B, Ruiz-Arguelles A, Basso G, Braylan R, Rothe G, Lacombe F, Lanza F, Papa S, Lucio P, San Miguel JF. Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions. Clin Chem 1999;45:1708-1717.
20. Rothe G, Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis. Leukemia 1996;10:877-895.
21. Roederer M. Compensation in flow cytometry. In: Robinson JP, Darzynkiewicz Z, Dean P, Orfao A, Rabinovitch P, Wheeless L, editors. Current protocols in cytometry. New York: John Wiley & Sons; 2000. p 1.14.1-1.14.19.
22. Sperr W, Escribano L, Jordan JH, Schernthaner GH, Kundi M, Horny H-P, Valent P. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Leuk Res 2001;25:529-536.
23. Valent P, Horny H-P, Escribano L, Longley-BJ J, Li CL, Schwartz LB, Marone G, Núñez R, Akin C, Sotlar K, Sperr W, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert AK, Metcalfe D, Vardiman JW, Bennet JM. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001;25:603-625.